CicloMed LLC   Report issue

For profit Phase 2
Founded: Kansas City MO United States (2015)

Organization Overview

First Clinical Trial
2018
NCT03348514
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

CicloMed LLC

Active Ingredients

Drugs in Phase 2 Trials (2)

cpx-pom (4 trials)

cytarabine (cytosar-u) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Neoplasms (Phase 1)

Urinary Bladder Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 2